acquired
Stage
1
Investors
About
Aerogen Inc developed, manufactured, and commercialized pulmonary drug delivery products and was acquired by Nektar in 2005.
Explore Aerogen Inc's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.